ARCHIVES

Blood Vessel Growth Inhibitor May Be Tested Against KS

This article is from The Cancer Letter archive.

Vol. 17 No. 33 | August 16, 1991

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Claim “Major Finding” In Treatment Of Soft Tissue Sarcoma With Three Modalities; 93% Survival

October 9, 1981

Clinical Trials: NIH Health Plans Association, Agree In Principle to Raise Clinical Trial Enrollment

March 5, 1999

Age Shouldn’t Determine Lung Cancer Treatment, ASCO Says In New Guideline

November 27, 2009

GAO Report Finds Hydrazine Sulfate Trials Were Accurate

September 29, 1995

Also M.D. Anderson awarded three new, one renewal SPORE grant.

October 31, 2003

NCI-Approved Clinical Trials

February 23, 2007